Skip to content
healthcare.dev

Zafirlukast

NDC 59651-292, Zafirlukast, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
59651-292
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213163
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-292 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZAFIRLUKAST20 mg/1

Pharmacologic classes

Cytochrome P450 2C9 Inhibitors [MoA]; Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]

Package NDCNDC-11Package
59651-292-605965102926060 TABLET, FILM COATED in 1 BOTTLE (59651-292-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8bdb47c5-9d19-4d59-94c8-62c117525e7f
  • NADAC price for package 59651029260

    GET /v1/drugs/nadac/59651029260

Use it

Look up 59651-292 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-292 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-292. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.